Cipla

{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,222.70",
    "chg": -33.15,
    "chgp": "-2.64%",
    "dir": -1,
    "prev_price": "1,255.85",
    "mcapval": "100,424.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE059A01026",
    "curr_date": "Mar 23",
    "curr_time": "",
    "bse_nse_vol": "13.6 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 23, 2026",
    "traded_date_str": "2026 03 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cipla-597145-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla Ltd. Falls to 52-Week Low of Rs 1234.45 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-stock-falls-to-52-week-low-of-rs123445-amid-market-downturn-3908094",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CiplaLtd_priceRelatedfactors_3908094.png",
        "date": "2026-03-23 13:48:47",
        "description": "For the fifth consecutive session, Cipla Ltd. closed lower, slipping to a fresh 52-week low of Rs 1234.45 on 23 Mar 2026, extending a decline that has now pushed the stock down nearly 26% from its 52-week high of Rs 1672.20."
      },
      {
        "title": "P/E at 21.42 vs Industry's 31.90: What the Data Shows for Cipla Ltd.",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amidst-nifty-50-membership-and-institutional-shifts-3906706",
        "imagepath": "",
        "date": "2026-03-23 09:20:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Discount Amid Sector Premiums</strong></p>\n                <p>The P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"stk\">Cipla Ltd.</a> at 21.42 is markedly lower than the sector average of 31.90, suggesting the market values the company’s earnings more conservatively than its peers. This 33% discount could reflect concerns over recent earnings momentum or broader sector headwinds. The pharmaceutical industry often commands premium valuations due to steady cash flows and defensive characteristics, so Cipla’s relative valuation gap invites scrutiny — <a href=\"https://www.marketsmojo.com/stocks-analysis/cipla-597145-0\" class=\"ctx\">is this discount justified by fundamentals or a potential opportunity?</a> Investors should ..."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges Amid Nifty 50 Membership and Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amid-nifty-50-membership-and-institutional-shifts-3902435",
        "imagepath": "",
        "date": "2026-03-20 09:20:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers Cipla Ltd. with considerable visibility and liquidity advantages. The index membership ensures that the stock is a key component for institutional investors, mutual funds, and exchange-traded funds (ETFs) that track the benchmark. This status typically supports a baseline demand for the stock, cushioning it against extreme volatility. However, Cipla’s recent performance indicates that index inclusion alone cannot shield it from sectoral and company-specific challenges.</p>\n\n                <p><strong>Recent Rating Downgrade and Mojo Score Analysis</strong></p>\n                <p>On 7 January 2026, Cipla’s Mojo Grade was downgraded from Hold to Sell, with a current Mojo ..."
      },
      {
        "title": "Cipla Ltd. Stock Falls to 52-Week Low of Rs.1258.15 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-stock-falls-to-52-week-low-of-rs125815-amid-continued-downtrend-3899887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CiplaLtd_priceRelatedfactors_3899887.png",
        "date": "2026-03-19 09:23:20",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.1258.15 today, marking a significant milestone in its recent price trajectory. The stock has been on a consistent decline, reflecting a series of financial and market factors that have influenced investor sentiment and valuation metrics."
      },
      {
        "title": "Cipla Ltd Faces Downward Pressure Amidst Nifty 50 Membership and Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-faces-downward-pressure-amidst-nifty-50-membership-and-sector-challenges-3899614",
        "imagepath": "",
        "date": "2026-03-19 09:20:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Significance</strong></p>\n                <p>As a large-cap stock with a market capitalisation exceeding ₹1,00,617 crore, Cipla’s inclusion in the Nifty 50 index underscores its importance to the Indian equity market. Membership in this benchmark index not only enhances visibility among domestic and global investors but also ensures significant passive fund inflows from index-tracking exchange-traded funds (ETFs) and mutual funds. This status typically provides a degree of price support and liquidity, making Cipla a bellwether for the Pharmaceuticals & Biotechnology sector.</p>\n                <p>However, Cipla’s recent price action suggests that index inclusion alone is insufficient to shield it from sector-specific headwinds and investor sentiment..."
      },
      {
        "title": "Cipla Ltd. Stock Falls to 52-Week Low of Rs.1275 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-stock-falls-to-52-week-low-of-rs1275-amidst-continued-downtrend-3898785",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CiplaLtd_priceRelatedfactors_3898785.png",
        "date": "2026-03-18 11:41:50",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.1275 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting a challenging phase for the company’s share price."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-as-a-nifty-50-pharmaceutical-giant-3898156",
        "imagepath": "",
        "date": "2026-03-18 09:20:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a constituent of the Nifty 50 index, Cipla Ltd. holds a critical position within India’s benchmark equity gauge. This membership not only reflects the company’s sizeable market capitalisation—currently standing at ₹1,03,500.94 crores—but also ensures substantial visibility among domestic and international investors. Inclusion in the index typically attracts passive fund flows from index-tracking mutual funds and exchange-traded funds (ETFs), which can provide a degree of price support and liquidity.</p>\n                <p>However, Cipla’s recent price action suggests that index membership alone is insufficient to shield it from sectoral and company-specific challenges. The stock closed near its 52-week low,..."
      },
      {
        "title": "Cipla Ltd. Stock Falls to 52-Week Low of Rs.1276.95 Amidst Broad Market Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-stock-falls-to-52-week-low-of-rs127695-amidst-broad-market-weakness-3896689",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CiplaLtd_priceRelatedfactors_3896689.png",
        "date": "2026-03-17 11:51:08",
        "description": "Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today at Rs.1276.95, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s share price."
      },
      {
        "title": "Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Institutional Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-ltd-navigating-challenges-amidst-nifty-50-membership-and-institutional-shifts-3896018",
        "imagepath": "",
        "date": "2026-03-17 09:20:38",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Cipla Ltd. This membership ensures that the stock is a key component in numerous index-tracking funds and institutional portfolios, thereby attracting steady investment flows. However, such inclusion also subjects the stock to heightened scrutiny and performance expectations. Cipla’s recent struggles have thus drawn attention not only from retail investors but also from large institutional holders who closely monitor benchmark constituents for portfolio rebalancing.</p>\n\n                <p><strong>Recent Rating Downgrade and Market Reaction</strong></p>\n                <p>On 7 January 2026, Cipla’s Mojo Grade was downg..."
      }
    ],
    "total": 974,
    "sid": "597145",
    "stock_news_url": "https://www.marketsmojo.com/news/cipla-597145"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "19-Mar-2026",
      "details": "Investment in Cipla (EU) Limited wholly owned subsidiary of the Company",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Amalgamation/ Merger / Demerger",
      "datetime": "19-Mar-2026",
      "details": "Scheme of Amalgamation between Inzpera Healthsciences Limited wholly owned subsidiary of the Company (Transferor Company) with the Company (Transferee Company)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "19-Mar-2026",
      "details": "Please find attached intimation regarding appointment of Vice Chairman and tenure completion of ID",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cipla Ltd. Falls to 52-Week Low of Rs 1234.45 as Sell-Off Deepens

2026-03-23 13:48:47

For the fifth consecutive session, Cipla Ltd. closed lower, slipping to a fresh 52-week low of Rs 1234.45 on 23 Mar 2026, extending a decline that has now pushed the stock down nearly 26% from its 52-week high of Rs 1672.20.

Read full news article

P/E at 21.42 vs Industry's 31.90: What the Data Shows for Cipla Ltd.

2026-03-23 09:20:42

Valuation Picture: Discount Amid Sector Premiums

The P/E ratio of Cipla Ltd. at 21.42 is markedly lower than the sector average of 31.90, suggesting the market values the company’s earnings more conservatively than its peers. This 33% discount could reflect concerns over recent earnings momentum or broader sector headwinds. The pharmaceutical industry often commands premium valuations due to steady cash flows and defensive characteristics, so Cipla’s relative valuation gap invites scrutiny — is this discount justified by fundamentals or a potential opportunity? Investors should ...

Read full news article

Cipla Ltd: Navigating Challenges Amid Nifty 50 Membership and Institutional Shifts

2026-03-20 09:20:47

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers Cipla Ltd. with considerable visibility and liquidity advantages. The index membership ensures that the stock is a key component for institutional investors, mutual funds, and exchange-traded funds (ETFs) that track the benchmark. This status typically supports a baseline demand for the stock, cushioning it against extreme volatility. However, Cipla’s recent performance indicates that index inclusion alone cannot shield it from sectoral and company-specific challenges.

Recent Rating Downgrade and Mojo Score Analysis

On 7 January 2026, Cipla’s Mojo Grade was downgraded from Hold to Sell, with a current Mojo ...

Read full news article

Cipla Ltd. Stock Falls to 52-Week Low of Rs.1258.15 Amid Continued Downtrend

2026-03-19 09:23:20

Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.1258.15 today, marking a significant milestone in its recent price trajectory. The stock has been on a consistent decline, reflecting a series of financial and market factors that have influenced investor sentiment and valuation metrics.

Read full news article

Cipla Ltd Faces Downward Pressure Amidst Nifty 50 Membership and Sector Challenges

2026-03-19 09:20:51

Index Membership and Market Significance

As a large-cap stock with a market capitalisation exceeding ₹1,00,617 crore, Cipla’s inclusion in the Nifty 50 index underscores its importance to the Indian equity market. Membership in this benchmark index not only enhances visibility among domestic and global investors but also ensures significant passive fund inflows from index-tracking exchange-traded funds (ETFs) and mutual funds. This status typically provides a degree of price support and liquidity, making Cipla a bellwether for the Pharmaceuticals & Biotechnology sector.

However, Cipla’s recent price action suggests that index inclusion alone is insufficient to shield it from sector-specific headwinds and investor sentiment...

Read full news article

Cipla Ltd. Stock Falls to 52-Week Low of Rs.1275 Amidst Continued Downtrend

2026-03-18 11:41:50

Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.1275 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting a challenging phase for the company’s share price.

Read full news article

Cipla Ltd: Navigating Challenges as a Nifty 50 Pharmaceutical Giant

2026-03-18 09:20:52

Significance of Nifty 50 Membership

As a constituent of the Nifty 50 index, Cipla Ltd. holds a critical position within India’s benchmark equity gauge. This membership not only reflects the company’s sizeable market capitalisation—currently standing at ₹1,03,500.94 crores—but also ensures substantial visibility among domestic and international investors. Inclusion in the index typically attracts passive fund flows from index-tracking mutual funds and exchange-traded funds (ETFs), which can provide a degree of price support and liquidity.

However, Cipla’s recent price action suggests that index membership alone is insufficient to shield it from sectoral and company-specific challenges. The stock closed near its 52-week low,...

Read full news article

Cipla Ltd. Stock Falls to 52-Week Low of Rs.1276.95 Amidst Broad Market Weakness

2026-03-17 11:51:08

Cipla Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low today at Rs.1276.95, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s share price.

Read full news article

Cipla Ltd: Navigating Challenges Amidst Nifty 50 Membership and Institutional Shifts

2026-03-17 09:20:38

Significance of Nifty 50 Membership

Being part of the Nifty 50 index confers considerable visibility and liquidity advantages to Cipla Ltd. This membership ensures that the stock is a key component in numerous index-tracking funds and institutional portfolios, thereby attracting steady investment flows. However, such inclusion also subjects the stock to heightened scrutiny and performance expectations. Cipla’s recent struggles have thus drawn attention not only from retail investors but also from large institutional holders who closely monitor benchmark constituents for portfolio rebalancing.

Recent Rating Downgrade and Market Reaction

On 7 January 2026, Cipla’s Mojo Grade was downg...

Read full news article

View All News